| Dr Anne M Conquest, MD | |
|
400 N State Of Franklin Rd Rm 2746, Johnson City, TN 37604-6035 | |
| (423) 431-6111 | |
| Not Available |
| Full Name | Dr Anne M Conquest |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 25 Years |
| Location | 400 N State Of Franklin Rd Rm 2746, Johnson City, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154358083 | NPI | - | NPPES |
| 620476822 | Other | TAX ID |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mission Health Community Multispecialty Providers Llc | 9537468574 | 577 |
News Archive
In other insurance company news, BlueCross Blue Shield of Illinois will pay $25M to settle coverage denial claims.
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy, announced that PPMD will provide a grant to clinical sites participating in Acceleron Pharma's Phase 2 clinical study of ACE-031. These grants will help patients' families cover travel costs to and from the study site, and hotel rooms and meals during study visits.
Rep. John Shadegg, R-Ariz., speaks as Reps. Joe Barton, R-Texas, and John Fleming, R-La., listen during a news conference. Shadegg held the news conference to discuss the costs of health care reform.
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY's midkine patent portfolio for the development of novel lung cancer diagnostics.
› Verified 3 days ago
| Entity Name | Mission Hospitals Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962452482 PECOS PAC ID: 0648189969 Enrollment ID: O20040309000878 |
News Archive
In other insurance company news, BlueCross Blue Shield of Illinois will pay $25M to settle coverage denial claims.
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy, announced that PPMD will provide a grant to clinical sites participating in Acceleron Pharma's Phase 2 clinical study of ACE-031. These grants will help patients' families cover travel costs to and from the study site, and hotel rooms and meals during study visits.
Rep. John Shadegg, R-Ariz., speaks as Reps. Joe Barton, R-Texas, and John Fleming, R-La., listen during a news conference. Shadegg held the news conference to discuss the costs of health care reform.
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY's midkine patent portfolio for the development of novel lung cancer diagnostics.
› Verified 3 days ago
| Entity Name | Blue Ridge Regional Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447261698 PECOS PAC ID: 0648181966 Enrollment ID: O20040729001574 |
News Archive
In other insurance company news, BlueCross Blue Shield of Illinois will pay $25M to settle coverage denial claims.
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy, announced that PPMD will provide a grant to clinical sites participating in Acceleron Pharma's Phase 2 clinical study of ACE-031. These grants will help patients' families cover travel costs to and from the study site, and hotel rooms and meals during study visits.
Rep. John Shadegg, R-Ariz., speaks as Reps. Joe Barton, R-Texas, and John Fleming, R-La., listen during a news conference. Shadegg held the news conference to discuss the costs of health care reform.
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY's midkine patent portfolio for the development of novel lung cancer diagnostics.
› Verified 3 days ago
| Entity Name | Mission Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114150190 PECOS PAC ID: 0749326106 Enrollment ID: O20100313000054 |
News Archive
In other insurance company news, BlueCross Blue Shield of Illinois will pay $25M to settle coverage denial claims.
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy, announced that PPMD will provide a grant to clinical sites participating in Acceleron Pharma's Phase 2 clinical study of ACE-031. These grants will help patients' families cover travel costs to and from the study site, and hotel rooms and meals during study visits.
Rep. John Shadegg, R-Ariz., speaks as Reps. Joe Barton, R-Texas, and John Fleming, R-La., listen during a news conference. Shadegg held the news conference to discuss the costs of health care reform.
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY's midkine patent portfolio for the development of novel lung cancer diagnostics.
› Verified 3 days ago
| Entity Name | Mission Hospitals Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548532021 PECOS PAC ID: 0648189969 Enrollment ID: O20120316000506 |
News Archive
In other insurance company news, BlueCross Blue Shield of Illinois will pay $25M to settle coverage denial claims.
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy, announced that PPMD will provide a grant to clinical sites participating in Acceleron Pharma's Phase 2 clinical study of ACE-031. These grants will help patients' families cover travel costs to and from the study site, and hotel rooms and meals during study visits.
Rep. John Shadegg, R-Ariz., speaks as Reps. Joe Barton, R-Texas, and John Fleming, R-La., listen during a news conference. Shadegg held the news conference to discuss the costs of health care reform.
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY's midkine patent portfolio for the development of novel lung cancer diagnostics.
› Verified 3 days ago
| Entity Name | Mission Health Community Multispecialty Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457719130 PECOS PAC ID: 9537468574 Enrollment ID: O20160426001883 |
News Archive
In other insurance company news, BlueCross Blue Shield of Illinois will pay $25M to settle coverage denial claims.
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy, announced that PPMD will provide a grant to clinical sites participating in Acceleron Pharma's Phase 2 clinical study of ACE-031. These grants will help patients' families cover travel costs to and from the study site, and hotel rooms and meals during study visits.
Rep. John Shadegg, R-Ariz., speaks as Reps. Joe Barton, R-Texas, and John Fleming, R-La., listen during a news conference. Shadegg held the news conference to discuss the costs of health care reform.
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY's midkine patent portfolio for the development of novel lung cancer diagnostics.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anne M Conquest, MD 1021 W Oakland Ave Ste 310, Johnson City, TN 37604-2192 Ph: (423) 302-6565 | Dr Anne M Conquest, MD 400 N State Of Franklin Rd Rm 2746, Johnson City, TN 37604-6035 Ph: (423) 431-6111 |
News Archive
In other insurance company news, BlueCross Blue Shield of Illinois will pay $25M to settle coverage denial claims.
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy, announced that PPMD will provide a grant to clinical sites participating in Acceleron Pharma's Phase 2 clinical study of ACE-031. These grants will help patients' families cover travel costs to and from the study site, and hotel rooms and meals during study visits.
Rep. John Shadegg, R-Ariz., speaks as Reps. Joe Barton, R-Texas, and John Fleming, R-La., listen during a news conference. Shadegg held the news conference to discuss the costs of health care reform.
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY's midkine patent portfolio for the development of novel lung cancer diagnostics.
› Verified 3 days ago
Dr. Melissa A Powell, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 N State Of Franklin Rd, Suite 130, Johnson City, TN 37604 Phone: 423-431-2477 Fax: 423-431-2478 | |
Dr. David Northern Walters, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: James H. Quillen/vamc, Corner Of Sidney And Lamont, Johnson City, TN 37684 Phone: 423-926-1171 Fax: 423-979-3477 | |
Dr. Rebecca Erion Odom, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2333 Knob Creek Rd Ste 16, Johnson City, TN 37604 Phone: 423-975-0764 Fax: 423-975-0141 | |
Michael J Allshouse, DO Surgery Medicare: Medicare Enrolled Practice Location: 325 N State Of Franklin Rd Fl 3, Johnson City, TN 37604 Phone: 423-439-7201 Fax: 423-439-7219 | |
Isaac William Browder, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 325 N State Of Franklin Rd, 3rd Floor, Johnson City, TN 37604 Phone: 423-439-7201 Fax: 423-439-7219 | |
Ryan M Landis, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 N State Of Franklin Rd Ste 130, Johnson City, TN 37604 Phone: 423-431-2477 Fax: 423-431-2478 | |
Tony O. Haley, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Professional Park Dr Ste 31, Johnson City, TN 37604 Phone: 423-975-5650 Fax: 423-975-5652 |